Documented reagents, by research area.

Triple-receptor agonist peptide. Studied across GLP-1, GIP and glucagon metabolic-signalling pathways.

Dual GIP/GLP-1 receptor agonist peptide. Reference compound for in-vitro metabolic receptor-signalling research.

Small-molecule NNMT inhibitor. Studied for adipocyte-metabolism and NAD-salvage pathways — a membrane-permeable metabolic research reagent.

Modified C-terminal fragment (176-191) of human growth hormone. Studied for lipolysis and fat-metabolism pathways — a research peptide with no reported IGF-1 or blood-glucose signaling in studies.

Long-acting GHRH-analogue peptide (with DAC). Studied for growth-hormone-axis signalling pathways.

Selective ghrelin-receptor (GH-secretagogue) pentapeptide. Studied for GH secretion-pathway research.

Synthetic growth-hormone-releasing hexapeptide and ghrelin-receptor agonist, studied for the growth-hormone secretion-axis pathway.

First-generation growth-hormone-releasing hexapeptide and GHS-R1a (ghrelin) receptor agonist, studied for the somatotropic secretagogue pathway.

Synthetic hexapeptide growth-hormone secretagogue, studied for the GHS-R1a and CD36 receptor signalling pathway.

Endogenous decapeptide ligand of the KISS1R/GPR54 receptor, studied for hypothalamic–pituitary–gonadal axis signalling pathways.

Found naturally in stomach secretions. Studied for tissue-repair and angiogenesis pathways.

Actin-sequestering peptide (synthetic Thymosin β-4). Studied for cell-migration and tissue-repair signalling pathways.

Copper-binding peptide. Studied for collagen synthesis and tissue-remodelling pathways in dermatological research.

Tuftsin-derived heptapeptide. Studied for anxiolytic and neuro-immune pathways — a Russian-developed research peptide.

ACTH(4-10)-derived peptide. Studied for cognitive and neuroprotective pathways — a Russian-developed research peptide.

Angiotensin-IV-derived oligopeptide. Studied for HGF/c-Met signalling and synaptogenesis pathways — a research reagent for cognition-focused in-vitro work.

Delta sleep-inducing peptide (DSIP). Studied for sleep-regulation and neuromodulatory pathways — a naturally-occurring research nonapeptide.

Khavinson short peptide bioregulator (Glu-Asp-Arg). Studied for neuroprotective and gene-regulation pathways — a Russian-developed research peptide.

Mitochondrial-derived peptide (16 residues). Studied for AMPK-signalling and metabolic-regulation pathways — a research peptide for cellular-bioenergetics work.

Small-molecule mitochondrial protonophore uncoupler. Studied for mitochondrial-uncoupling and metabolic-flexibility pathways — a research reagent for in-vitro bioenergetics.

Nicotinamide adenine dinucleotide — a redox coenzyme, not a peptide. Studied for cellular-energy, sirtuin, and NAD-metabolism pathways in vitro.

Mitochondria-targeting tetrapeptide (Elamipretide). Studied for cardiolipin-binding and mitochondrial-bioenergetics pathways — a cell-penetrating research peptide.

Synthetic tetrapeptide (Ala-Glu-Asp-Gly). Studied for telomerase-activity and circadian-rhythm pathways — a Russian-developed research peptide.

Mitochondrial-derived 24-residue peptide encoded in the MT-RNR2 region. Studied for cytoprotective and cellular-stress-response pathways — a longevity-focused research reagent.

Immunomodulatory peptide. Studied for decades in inflammation and host-defense research.

α-MSH-derived tripeptide (Lys-Pro-Val). Studied for anti-inflammatory and NF-κB-modulation pathways — a research reagent for immune-signaling work.

Human cathelicidin-derived antimicrobial peptide. Studied for host-defense and immunomodulatory pathways — a research reagent for innate-immunity work.

Thymus-derived polypeptide complex (peptide bioregulator), studied for immune-regulation and cellular-senescence research pathways.